Comment from Gautam Nick

AnonymousSupportIndividual
Summary: An individual patient or family member advocates for the approval of Anktiva for the treatment of Glioblastoma. They argue that the disease is rapidly progressive and devastating, emphasizing the urgent need for treatment options for patients with limited hope.
Pardon the pun, but allowing Anktiva for Glioblastoma is a no brainer. Once a patient has Glioblastoma, the only question is how fast will it take to destroy the patient? To steal their mobility, their ability to talk intelligently, hear. Glio is like a stroke that gets worse often by the week. It is cruel and presently patients have no real hope. If those who read this and decide what can be allowed for these poor individuals, we're to be suddenly struck or any of their family members, then all of a sudden, the person's at the FDA, would say "oh my god, I need this Anktiva today, not in 6 months"

View on Regulations.gov